Pfizer's RA pill Xeljanz gets nod, could erode biologic sales
November 07 2012
Pfizer's hoping its new RA drug can carve out a niche by pushing back physicians' use of biologics and winning ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.